• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄酮类化合物的药理作用研究进展:计算机模拟的系统评价。

Insights into the Pharmacological Effects of Flavonoids: The Systematic Review of Computer Modeling.

机构信息

Laboratoty of Nanobiotechnology, Institute of Biomedical Chemistry, Pogodinskaya Str. 10/8, 119121 Moscow, Russia.

Department of Chemistry, Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.

出版信息

Int J Mol Sci. 2022 May 27;23(11):6023. doi: 10.3390/ijms23116023.

DOI:10.3390/ijms23116023
PMID:35682702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9181432/
Abstract

Computer modeling is a method that is widely used in scientific investigations to predict the biological activity, toxicity, pharmacokinetics, and synthesis strategy of compounds based on the structure of the molecule. This work is a systematic review of articles performed in accordance with the recommendations of PRISMA and contains information on computer modeling of the interaction of classical flavonoids with different biological targets. The review of used computational approaches is presented. Furthermore, the affinities of flavonoids to different targets that are associated with the infection, cardiovascular, and oncological diseases are discussed. Additionally, the methodology of bias risks in molecular docking research based on principles of evidentiary medicine was suggested and discussed. Based on this data, the most active groups of flavonoids and lead compounds for different targets were determined. It was concluded that flavonoids are a promising object for drug development and further research of pharmacology by in vitro, ex vivo, and in vivo models is required.

摘要

计算机建模是一种广泛应用于科学研究的方法,可根据分子结构预测化合物的生物活性、毒性、药代动力学和合成策略。本工作是按照 PRISMA 建议进行的文章系统评价,其中包含关于经典类黄酮与不同生物靶标相互作用的计算机建模信息。介绍了所使用的计算方法。此外,还讨论了类黄酮与与传染病、心血管和肿瘤疾病相关的不同靶标之间的亲和力。此外,还根据循证医学的原则提出并讨论了基于分子对接研究中偏倚风险的方法学。基于这些数据,确定了不同靶标中最活跃的类黄酮和先导化合物。结论是类黄酮是药物开发的有前途的对象,需要进一步通过体外、离体和体内模型进行药理学研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2356/9181432/8a2a52a4f6d6/ijms-23-06023-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2356/9181432/2c5a1986b7d5/ijms-23-06023-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2356/9181432/d55bdc4de51d/ijms-23-06023-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2356/9181432/efee1b7a16e8/ijms-23-06023-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2356/9181432/888c456d7eb8/ijms-23-06023-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2356/9181432/98e1fb648446/ijms-23-06023-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2356/9181432/b078fe9143b5/ijms-23-06023-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2356/9181432/8a2a52a4f6d6/ijms-23-06023-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2356/9181432/2c5a1986b7d5/ijms-23-06023-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2356/9181432/d55bdc4de51d/ijms-23-06023-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2356/9181432/efee1b7a16e8/ijms-23-06023-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2356/9181432/888c456d7eb8/ijms-23-06023-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2356/9181432/98e1fb648446/ijms-23-06023-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2356/9181432/b078fe9143b5/ijms-23-06023-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2356/9181432/8a2a52a4f6d6/ijms-23-06023-g007.jpg

相似文献

1
Insights into the Pharmacological Effects of Flavonoids: The Systematic Review of Computer Modeling.黄酮类化合物的药理作用研究进展:计算机模拟的系统评价。
Int J Mol Sci. 2022 May 27;23(11):6023. doi: 10.3390/ijms23116023.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
3
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
5
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
6
Psychological and/or educational interventions for the prevention of depression in children and adolescents.预防儿童和青少年抑郁症的心理和/或教育干预措施。
Cochrane Database Syst Rev. 2004(1):CD003380. doi: 10.1002/14651858.CD003380.pub2.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Silicone gel sheeting for treating hypertrophic scars.硅凝胶片治疗增生性瘢痕。
Cochrane Database Syst Rev. 2021 Sep 26;9(9):CD013357. doi: 10.1002/14651858.CD013357.pub2.
10
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.

引用本文的文献

1
Peptides Evaluated In Silico, In Vitro, and In Vivo as Therapeutic Tools for Obesity: A Systematic Review.经计算机模拟、体外和体内评估的用于肥胖治疗的肽类:系统综述。
Int J Mol Sci. 2024 Sep 6;25(17):9646. doi: 10.3390/ijms25179646.
2
In Silico Screening of Therapeutic Targets as a Tool to Optimize the Development of Drugs and Nutraceuticals in the Treatment of Diabetes : A Systematic Review.基于计算机的治疗靶点筛选:优化糖尿病药物和营养保健品研发的工具——系统综述
Int J Mol Sci. 2024 Aug 25;25(17):9213. doi: 10.3390/ijms25179213.
3
Proteins and Peptides Studied In Silico and In Vivo for the Treatment of Diabetes Mellitus: A Systematic Review.

本文引用的文献

1
The Effect of Dietary Polyphenols on Vascular Health and Hypertension: Current Evidence and Mechanisms of Action.膳食多酚对血管健康和高血压的影响:当前证据及作用机制
Nutrients. 2022 Jan 27;14(3):545. doi: 10.3390/nu14030545.
2
Bioavailability and Safety of Dihydroquercetin (Review).二氢槲皮素的生物利用度与安全性(综述)
Pharm Chem J. 2022;55(11):1133-1137. doi: 10.1007/s11094-022-02548-8. Epub 2022 Feb 11.
3
Pharmacokinetics and drug-likeness of antidiabetic flavonoids: Molecular docking and DFT study.抗糖尿病类黄酮的药代动力学和类药性:分子对接和密度泛函理论研究。
糖尿病治疗的体内和体外研究的蛋白质和肽:系统评价。
Nutrients. 2024 Jul 24;16(15):2395. doi: 10.3390/nu16152395.
4
Insights into the stereoisomerism of dihydroquercetin: analytical and pharmacological aspects.二氢槲皮素立体异构现象的研究进展:分析与药理学方面
Front Chem. 2024 Jul 5;12:1439167. doi: 10.3389/fchem.2024.1439167. eCollection 2024.
5
Insights into the computer-aided drug design and discovery based on anthraquinone scaffold for cancer treatment: A systematic review.基于蒽醌骨架的计算机辅助药物设计与发现用于癌症治疗的研究进展:系统综述。
PLoS One. 2024 May 22;19(5):e0301396. doi: 10.1371/journal.pone.0301396. eCollection 2024.
6
Differential metabolite analysis of the pharmacodynamic differences between different ratios of Dahuang ()-Taoren () herb pair.大黄()-桃仁()药对对药效差异的差异代谢物分析。
J Tradit Chin Med. 2024 Jun;44(3):515-523. doi: 10.19852/j.cnki.jtcm.20240423.006.
7
Anti-Obesity Therapeutic Targets Studied In Silico and In Vivo: A Systematic Review.抗肥胖治疗靶点的体内外研究:系统评价。
Int J Mol Sci. 2024 Apr 25;25(9):4699. doi: 10.3390/ijms25094699.
8
Identification of cholinesterases inhibitors from flavonoids derivatives for possible treatment of Alzheimer's disease: and approaches.从黄酮类衍生物中鉴定胆碱酯酶抑制剂用于阿尔茨海默病的可能治疗:方法与途径。
Curr Res Struct Biol. 2024 Apr 25;7:100146. doi: 10.1016/j.crstbi.2024.100146. eCollection 2024.
9
Drug repurposing screen to identify inhibitors of the RNA polymerase (nsp12) and helicase (nsp13) from SARS-CoV-2 replication and transcription complex.针对 SARS-CoV-2 复制和转录复合物的 RNA 聚合酶(nsp12)和解旋酶(nsp13)抑制剂的药物再利用筛选。
Virus Res. 2024 May;343:199356. doi: 10.1016/j.virusres.2024.199356. Epub 2024 Mar 16.
10
Modification of the Physicochemical Properties of Active Pharmaceutical Ingredients via Lyophilization.通过冻干法对活性药物成分的物理化学性质进行改性。
Pharmaceutics. 2023 Nov 9;15(11):2607. doi: 10.3390/pharmaceutics15112607.
PLoS One. 2021 Dec 10;16(12):e0260853. doi: 10.1371/journal.pone.0260853. eCollection 2021.
4
The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial.槲皮素联合抗病毒药物对COVID-19住院患者的治疗效果:一项随机对照试验。
Eur J Pharmacol. 2022 Jan 5;914:174615. doi: 10.1016/j.ejphar.2021.174615. Epub 2021 Dec 2.
5
Haste makes waste: A critical review of docking-based virtual screening in drug repurposing for SARS-CoV-2 main protease (M-pro) inhibition.欲速则不达:基于对接的虚拟筛选在 SARS-CoV-2 主蛋白酶(M-pro)抑制药物再利用中的批判性评价。
Med Res Rev. 2022 Mar;42(2):744-769. doi: 10.1002/med.21862. Epub 2021 Oct 26.
6
A practical guide to large-scale docking.大规模对接的实用指南。
Nat Protoc. 2021 Oct;16(10):4799-4832. doi: 10.1038/s41596-021-00597-z. Epub 2021 Sep 24.
7
In silico methods and tools for drug discovery.基于计算机的药物研发方法和工具。
Comput Biol Med. 2021 Oct;137:104851. doi: 10.1016/j.compbiomed.2021.104851. Epub 2021 Sep 8.
8
Pharmacological basis and new insights of taxifolin: A comprehensive review.金雀异黄素的药理学基础及新认识:全面综述。
Biomed Pharmacother. 2021 Oct;142:112004. doi: 10.1016/j.biopha.2021.112004. Epub 2021 Aug 10.
9
Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review.计算机辅助药物设计的现状及通过计算技术发现的药物的亮点:综述。
Eur J Med Chem. 2021 Nov 15;224:113705. doi: 10.1016/j.ejmech.2021.113705. Epub 2021 Jul 15.
10
screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2.筛选植物多酚类化合物,以鉴定新型蛋白酶抑制剂,有效对抗 SARS-CoV-2。
J Biomol Struct Dyn. 2022;40(20):10437-10453. doi: 10.1080/07391102.2021.1944909. Epub 2021 Jun 28.